Connection

Marcus Mall to Humans

This is a "connection" page, showing publications Marcus Mall has written about Humans.
Connection Strength

0.110
  1. Emerging Concepts and Therapies for Mucoobstructive Lung Disease. Ann Am Thorac Soc. 2018 11; 15(Suppl 3):S216-S226.
    View in: PubMed
    Score: 0.006
  2. Multicentre standardisation of chest MRI as radiation-free outcome measure of lung disease in young children with cystic fibrosis. J Cyst Fibros. 2018 07; 17(4):518-527.
    View in: PubMed
    Score: 0.006
  3. Ion Channel Modulators in Cystic Fibrosis. Chest. 2018 08; 154(2):383-393.
    View in: PubMed
    Score: 0.006
  4. Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis. Eur Respir J. 2018 03; 51(3).
    View in: PubMed
    Score: 0.006
  5. Mucopurulent Triggering of the Airway Epithelium. Implications in Health and Cystic Fibrosis. Am J Respir Crit Care Med. 2018 02 15; 197(4):418-420.
    View in: PubMed
    Score: 0.006
  6. An informative intragenic microsatellite marker suggests the IL-1 receptor as a genetic modifier in cystic fibrosis. Eur Respir J. 2017 12; 50(6).
    View in: PubMed
    Score: 0.006
  7. Three-center feasibility of lung clearance index in infants and preschool children with cystic fibrosis and other lung diseases. J Cyst Fibros. 2018 03; 17(2):249-255.
    View in: PubMed
    Score: 0.006
  8. Rare cause for hemoptysis in an adolescent: Bronchial capillary hemangioma. Pediatr Pulmonol. 2017 07; 52(7):E40-E42.
    View in: PubMed
    Score: 0.006
  9. Airway mucus, inflammation and remodeling: emerging links in the pathogenesis of chronic lung diseases. Cell Tissue Res. 2017 03; 367(3):537-550.
    View in: PubMed
    Score: 0.006
  10. MRI accelerating progress in functional assessment of cystic fibrosis lung disease. J Cyst Fibros. 2017 03; 16(2):165-167.
    View in: PubMed
    Score: 0.006
  11. Five years of experience with biochemical cystic fibrosis newborn screening based on IRT/PAP in Germany. Pediatr Pulmonol. 2015 Jul; 50(7):655-64.
    View in: PubMed
    Score: 0.005
  12. A new player in the game: epithelial cathepsin S in early cystic fibrosis lung disease. Am J Respir Crit Care Med. 2014 Jul 15; 190(2):126-7.
    View in: PubMed
    Score: 0.005
  13. Renewed Absence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections in the Day Care Context in Berlin, January 2021. Clin Infect Dis. 2021 11 16; 73(10):1944-1945.
    View in: PubMed
    Score: 0.002
  14. SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany-a cross-sectional study. Eur J Public Health. 2021 10 26; 31(5):1105-1107.
    View in: PubMed
    Score: 0.002
  15. Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination. Science. 2021 10 08; 374(6564):eabh1823.
    View in: PubMed
    Score: 0.002
  16. SARS-CoV-2 infection and transmission in school settings during the second COVID-19 wave: a cross-sectional study, Berlin, Germany, November 2020. Euro Surveill. 2021 08; 26(34).
    View in: PubMed
    Score: 0.002
  17. Self-collected oral, nasal and saliva samples yield sensitivity comparable to professionally collected oro-nasopharyngeal swabs in SARS-CoV-2 diagnosis among symptomatic outpatients. Int J Infect Dis. 2021 Sep; 110:261-266.
    View in: PubMed
    Score: 0.002
  18. Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1. J Clin Invest. 2021 07 15; 131(14).
    View in: PubMed
    Score: 0.002
  19. SARS-CoV-2 in severe COVID-19 induces a TGF-ß-dominated chronic immune response that does not target itself. Nat Commun. 2021 03 30; 12(1):1961.
    View in: PubMed
    Score: 0.002
  20. SARS-CoV-2 Infection, Risk Perception, Behaviour and Preventive Measures at Schools in Berlin, Germany, during the Early Post-Lockdown Phase: A Cross-Sectional Study. Int J Environ Res Public Health. 2021 03 08; 18(5).
    View in: PubMed
    Score: 0.002
  21. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020 11; 587(7833):270-274.
    View in: PubMed
    Score: 0.002
  22. Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19). Infection. 2020 Aug; 48(4):619-626.
    View in: PubMed
    Score: 0.002
  23. Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis. J Cyst Fibros. 2019 07; 18(4):536-542.
    View in: PubMed
    Score: 0.002
  24. VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. N Engl J Med. 2018 10 25; 379(17):1599-1611.
    View in: PubMed
    Score: 0.002
  25. Assessment of Suspected Vascular Rings and Slings and/or Airway Pathologies Using Magnetic Resonance Imaging Rather Than Computed Tomography. Respiration. 2019; 97(2):108-118.
    View in: PubMed
    Score: 0.002
  26. Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis. J Cyst Fibros. 2018 11; 17(6):715-722.
    View in: PubMed
    Score: 0.002
  27. Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis. Am J Respir Crit Care Med. 2018 06 01; 197(11):1433-1442.
    View in: PubMed
    Score: 0.002
  28. Validation of automated lobe segmentation on paired inspiratory-expiratory chest CT in 8-14 year-old children with cystic fibrosis. PLoS One. 2018; 13(4):e0194557.
    View in: PubMed
    Score: 0.002
  29. Non-contrast enhanced magnetic resonance imaging detects mosaic signal intensity in early cystic fibrosis lung disease. Eur J Radiol. 2018 Apr; 101:178-183.
    View in: PubMed
    Score: 0.002
  30. Reply to Verbanck and Vanderhelst: The Respective Roles of Lung Clearance Index and Magnetic Resonance Imaging in the Clinical Management of Patients with Cystic Fibrosis. Am J Respir Crit Care Med. 2018 02 01; 197(3):410-411.
    View in: PubMed
    Score: 0.002
  31. One time quantitative PCR detection of Pseudomonas aeruginosa to discriminate intermittent from chronic infection in cystic fibrosis. J Cyst Fibros. 2018 05; 17(3):348-355.
    View in: PubMed
    Score: 0.002
  32. Bypassing CFTR dysfunction in cystic fibrosis with alternative pathways for anion transport. Curr Opin Pharmacol. 2017 06; 34:91-97.
    View in: PubMed
    Score: 0.001
  33. Chronic but not intermittent infection with Pseudomonas aeruginosa is associated with global changes of the lung microbiome in cystic fibrosis. Eur Respir J. 2017 10; 50(4).
    View in: PubMed
    Score: 0.001
  34. Gene signature driving invasive mucinous adenocarcinoma of the lung. EMBO Mol Med. 2017 04; 9(4):462-481.
    View in: PubMed
    Score: 0.001
  35. Dephasing and diffusion on the alveolar surface. Phys Rev E. 2017 Feb; 95(2-1):022415.
    View in: PubMed
    Score: 0.001
  36. Protean proteases: at the cutting edge of lung diseases. Eur Respir J. 2017 02; 49(2).
    View in: PubMed
    Score: 0.001
  37. Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies. Eur Respir J. 2017 01; 49(1).
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.